...
首页> 外文期刊>Methods: A Companion to Methods in Enzymology >Fabrication and characterization of injectable hydrogels derived from decellularized skeletal and cardiac muscle
【24h】

Fabrication and characterization of injectable hydrogels derived from decellularized skeletal and cardiac muscle

机译:脱细胞骨骼肌和心肌注射用水凝胶的制备与表征

获取原文
获取原文并翻译 | 示例
           

摘要

Biomaterials, which can contain appropriate biomechanical and/or biochemical cues, are increasingly being investigated as potential scaffolds for tissue regeneration and/or repair for treating myocardial infarction, heart failure, and peripheral artery disease. Specifically, injectable hydrogels are touted for their minimally invasive delivery, ability to self-assemble in situ, and capacity to encourage host tissue regeneration. Here we present detailed methods for fabricating and characterizing decellularized injectable cardiac and skeletal muscle extracellular matrix (ECM) hydrogels. The ECM derived hydrogels have low cellular and DNA content, retain sulfated glycosaminoglycans and other extracellular matrix proteins such as collagen, gel at physiologic temperature and pH, and assume a nanofibrous architecture. These injectable hydrogels are amenable to minimally invasive, tissue specific biomaterial therapies for treating myocardial infarction and peripheral artery disease. (C) 2015 Elsevier Inc. All rights reserved.
机译:包含适当的生物力学和/或生化线索的生物材料正日益被研究用作组织再生和/或修复的潜在支架,以治疗心肌梗塞,心力衰竭和周围动脉疾病。特别地,吹捧可注射水凝胶的微创传递,原位自组装能力以及促进宿主组织再生的能力。在这里,我们介绍制造和表征脱细胞的可注射的心脏和骨骼肌细胞外基质(ECM)水凝胶的详细方法。 ECM衍生的水凝胶的细胞和DNA含量低,在生理温度和pH值下保留硫酸化的糖胺聚糖和其他细胞外基质蛋白(如胶原蛋白,凝胶),并具有纳米纤维结构。这些可注射的水凝胶适合用于治疗心肌梗塞和外周动脉疾病的微创,组织特异性生物材料疗法。 (C)2015 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号